Top Markets
Coin of the day
Oncoinvent ASA Oncoinvent ASA

Oncoinvent ASA

ONCIN
Clasificación en acciones #26813
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Precio por acción
$8.39
Capitalización bursátil
$37.55M
Cambio (1 día)
-7.83%
Cambio (1 año)
-26.06%
País
NO
Comercio Oncoinvent ASA (ONCIN)

Categoría

Ratio P/B de Oncoinvent ASA (ONCIN)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Oncoinvent ASA, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Oncoinvent ASA desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH